AM-1638 |
AM-1638 : Full Agonist of FFAR1
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| FFAR1 |
|
Full Agonist
up to 1 uM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
AM-1638 did not activate the receptors GPR41 (FFAR3) and GPR43 (FFAR2) up to 10 µM, but had weak ...
Potency Cellular
In Vitro
FFAR1
Mode of Action: Full Agonist
Structure-Activity-Relationship data available? No
In Vivo Validations
Mouse, Rat, Cyno
Dose: 1 mg/kg, iv; 5 mg/kg, po (M), 0.5 mg/kg, iv; 2 mg/kg, po (R), 0.5 mg/kg, iv; 2 mg/kg, po (C), up to 100 mg/Kg po
Route of delivery:
Intravenous, Oral
Plasma half life:
2.0 (M), 1.8 (R), 2.1 (C) h
Systemic clearance:
0.18 (M), 0.91 (R), 0.81 (C) L/h/Kg
Reference: --
Chemical Information
| Molecular Formula | C33H35FO4 |
| SMILEs | COc1ccc(F)c(-c2ccc(COc3cccc([C@@H](CC(=O)O)C4CC4)c3)cc2C2=CCCC2(C)C)c1 |
| InChI | InChI=1S/C33H35FO4/c1-33(2)15-5-8-30(33)28-16-21(9-13-26(28)29-18-24(37-3)12-14-31(29)34)20-38-25-7-4-6-23(17-25)27(19-32(35)36)22-10-11-22/h4,6-9,12-14,16-18,22,27H,5,10-11,15,19-20H2,1-3H3,(H,35,36)/t27-/m0/s1 |
| Molecular weight | 514.25 Da |
| AlogP | 8.252 |
| HBond acceptors | 4 |
| HBond donors | 1 |
| Atoms | 73 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.